Trial NCT02086487

View at ClinicalTrials.gov 
Org. Study IDs: RC12/052

Last trial update was posted on 2017-03-07

MeSH Interventions

Nilotinib

MeSH Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Other Conditions

Myeloid Leukemia, Chronic

Stopping Reasons

Because of many unseen obstacles resulted in poor accrual, study is terminated.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID